Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

HIV Infection

Free Subscription 25.03.2024 5 AIDS 2 AIDS Res Hum Retroviruses 1 Am J Med 7 Clin Infect Dis 4 HIV Med 1 J Acquir Immune Defic Syndr 1 J Clin Oncol 1 J Infect Dis 2 J Med Virol 1 J Pediatr 2 J Virol 1 JAMA 1 Lancet 1 Lancet Infect Dis 1 Lancet Neurol 1 MMWR Morb Mortal Wkly Rep 1 Neurol Clin Pract 3 PLoS Med 4 PLoS One 1 PLoS Pathog 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. KEMP CG, Pence BW, Velloza J, Concepcion T, et al
   Cumulative exposure to depressive symptoms and all-cause mortality among adults living with HIV in Kenya, Nigeria, Tanzania, and Uganda.
   AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003891.
   PubMed         Abstract available
   
   
2. MIGISHA R, Chen G, Muyindike WR, Aung TN, et al
   Regional variation in weight change after the transition to dolutegravir: a prospective cohort study in Uganda and South Africa.
   AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003888.
   PubMed         Abstract available
   
   
3. HAW NJL, Lesko CR, Ng DK, Lam J, et al
   Incidence of non-AIDS defining comorbidities among young adults with perinatally-acquired HIV in North America, 2000-2019.
   AIDS. 2024 Mar 19. doi: 10.1097/QAD.0000000000003892.
   PubMed         Abstract available
   
   
4. CHOLLI PA, Buchacz KM, Harris NS, Crim SM, et al
   Self-rated Health and HIV Outcomes Among Adults with Diagnosed HIV - Medical Monitoring Project, United States, 2020-21.
   AIDS. 2024 Mar 20. doi: 10.1097/QAD.0000000000003890.
   PubMed         Abstract available
   
   
5. HU FH, Tang XL, Ge MW, Jia YJ, et al
   Mortality of children and adolescents co-infected with tuberculosis and HIV: a systematic review and meta-analysis.
   AIDS. 2024 Mar 18. doi: 10.1097/QAD.0000000000003886.
   PubMed         Abstract available
   
   

   
   AIDS Res Hum Retroviruses

6. LAN C, Zhu B, Hailong Z, Yuting S, et al
   Near Full-Length Genome Characterization of two Novel Unique Recombinants (CRF01_AE/CRF07_BC) in Beijing, China.
   AIDS Res Hum Retroviruses. 2024 Mar 22. doi: 10.1089/AID.2023.0149.
   PubMed         Abstract available
   
   
7. LE BRAZIDEC DL, Cormier K, Almonte A, Napoleon S, et al
   Pre-Exposure Prophylaxis Care Cascade Among Men Who Have Sex with Men Engaging in Partner Notification Services at a Sexually Transmitted Infections Clinic.
   AIDS Res Hum Retroviruses. 2024 Mar 18. doi: 10.1089/aid.2023.0097.
   PubMed         Abstract available
   
   

   
   Am J Med

8. ALI K, Wiemer L, Ali AA, Quan A, et al
   Gastrointestinal Bleeding Related to Visceral Kaposi Sarcoma.
   Am J Med. 2024 Mar 16:S0002-9343(24)00171-2. doi: 10.1016/j.amjmed.2024.
   PubMed        
   
   

   
   Clin Infect Dis

9. KRISHNAN S, Chaisson RE
   US Guidelines Fall Short on Short-Course Tuberculosis-Preventive Therapy.
   Clin Infect Dis. 2024;78:514-517.
   PubMed         Abstract available
   
   
10. BOODMAN C, Gupta N, Nelson CA, van Griensven J, et al
    Bartonella quintana Endocarditis: A Systematic Review of Individual Cases.
    Clin Infect Dis. 2024;78:554-561.
    PubMed         Abstract available
    
    
11. KENYON C
    We should not downplay the risks that doxycycline PEP will select for AMR.
    Clin Infect Dis. 2024 Mar 19:ciae139. doi: 10.1093.
    PubMed        
    
    
12. HAZRA A, Celum C, Luetkemeyer AF, Molina JM, et al
    Risk of antimicrobial resistance with doxy-PEP is real, as is the need for its well-Informed implementation.
    Clin Infect Dis. 2024 Mar 19:ciae152. doi: 10.1093.
    PubMed        
    
    
13. NGUYEN Q, Wooten D, Lee D, Moreno M, et al
    GLP-1 Receptor Agonists Promote Weight Loss Among People with HIV.
    Clin Infect Dis. 2024 Mar 19:ciae151. doi: 10.1093.
    PubMed         Abstract available
    
    
14. VALIN N, Lambert-Niclot S, Torres E, Meynard JL, et al
    A Human Immunodeficiency Virus Superinfection Diagnosed in a Patient on Intramuscular Long-acting Combination of Cabotegravir and Rilpivirine.
    Clin Infect Dis. 2024 Mar 21:ciad757. doi: 10.1093.
    PubMed         Abstract available
    
    
15. VANBAELEN T, Tsoumanis A, Kenyon C
    Total Antimicrobial Consumption in Doxycycline Postexposure Prophylaxis Cohorts and the Intensity of Screening for Bacterial Sexually Transmitted Infections.
    Clin Infect Dis. 2024;78:803-805.
    PubMed        
    
    

    
    HIV Med

16. SOCIAS ME, Cui Z, Le Foll B, Lei J, et al
    Sexually transmitted and blood-borne infection risk reduction with methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: Findings from a Canadian pragmatic randomized trial.
    HIV Med. 2024 Mar 20. doi: 10.1111/hiv.13636.
    PubMed         Abstract available
    
    
17. ZOU S, Chen Z, Tan Y, Tan M, et al
    Microbiomes detected by cerebrospinal fluid metagenomic next-generation sequencing among patients with and without HIV with suspected central nervous system infection.
    HIV Med. 2024 Mar 21. doi: 10.1111/hiv.13634.
    PubMed         Abstract available
    
    
18. JACOBS TG, Okemo D, Ssebagereka A, Mwehonge K, et al
    Availability and stock-outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda.
    HIV Med. 2024 Mar 18. doi: 10.1111/hiv.13635.
    PubMed         Abstract available
    
    
19. DOU Y, Lu R, Su L, Lan K, et al
    Efficacy of dolutegravir + lamivudine q.d. with food in people with TB/HIV using a rifampicin-based regimen: A retrospective observational case series.
    HIV Med. 2024 Mar 17. doi: 10.1111/hiv.13632.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

20. ERENRICH RK, Braun RA, Torres-Mendoza DM, Stevenson OL, et al
    Effectiveness of PrEPTECH: Findings From a 180-Day Randomized Controlled Trial of a Pre-Exposure Prophylaxis Telehealth Intervention.
    J Acquir Immune Defic Syndr. 2024;95:463-469.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

21. MCGEE-AVILA JK, Suneja G, Engels EA, Rositch AF, et al
    Cancer Treatment Disparities in People With HIV in the United States, 2001-2019.
    J Clin Oncol. 2024 Mar 21:JCO2302366. doi: 10.1200/JCO.23.02366.
    PubMed         Abstract available
    
    

    
    J Infect Dis

22. ZEEB M, Frischknecht P, Huber M, Schenkel CD, et al
    Genetic diversity from proviral DNA as a proxy for time since HIV-1 infection.
    J Infect Dis. 2024 Mar 20:jiae149. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

23. WANG Z
    Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile.
    J Med Virol. 2024;96:e29553.
    PubMed        
    
    
24. TRUNFIO M, Tang B, Okwuegbuna O, Iudicello JE, et al
    Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllers.
    J Med Virol. 2024;96:e29550.
    PubMed         Abstract available
    
    

    
    J Pediatr

25. BARRIOS-TASCON A, Strehlau R, Patel F, Burke M, et al
    Growth Trajectories over the First Year of Life among Early-treated Infants with HIV and Infants Who Are HIV-exposed Uninfected.
    J Pediatr. 2024 Mar 18:114018. doi: 10.1016/j.jpeds.2024.114018.
    PubMed         Abstract available
    
    

    
    J Virol

26. VON MALTITZ P, Wettstein L, Weil T, Schommers P, et al
    Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.
    J Virol. 2024 Mar 19:e0119023. doi: 10.1128/jvi.01190.
    PubMed         Abstract available
    
    
27. TWENTYMAN J, Emerman M, Ohainle M
    Capsid-dependent lentiviral restrictions.
    J Virol. 2024 Mar 18:e0030824. doi: 10.1128/jvi.00308.
    PubMed         Abstract available
    
    

    
    JAMA

28. SHETH AN, Momplaisir F, Dumond JB
    Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women.
    JAMA. 2024;331:912-914.
    PubMed        
    
    

    
    Lancet

29. WATTS G
    Andrew Kerkhoff: award-winning TB and HIV physician-scientist.
    Lancet. 2024 Mar 15:S0140-6736(24)00539-7. doi: 10.1016/S0140-6736(24)00539.
    PubMed        
    
    

    
    Lancet Infect Dis

30. STUCK L, Klinkenberg E, Abdelgadir Ali N, Basheir Abukaraig EA, et al
    Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis.
    Lancet Infect Dis. 2024 Mar 12:S1473-3099(24)00011.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

31. 
    Global, regional, and national burden of disorders affecting the nervous system, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet Neurol. 2024;23:344-381.
    PubMed         Abstract available
    
    

    
    MMWR Morb Mortal Wkly Rep

32. AJIBOYE AS, O'Connor S, Smith JP, Ahmedov S, et al
    Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:233-238.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

33. MBONDE AA, Chang J, Musubire AK, Okello S, et al
    HIV Infection and 90-Day Stroke Outcomes in Uganda: A Prospective Observational Cohort Study.
    Neurol Clin Pract. 2023;13:e200198.
    PubMed         Abstract available
    
    

    
    PLoS Med

34. EMANI S, Alves K, Alves LC, da Silva DA, et al
    Quantifying gaps in the tuberculosis care cascade in Brazil: A mathematical model study using national program data.
    PLoS Med. 2024;21:e1004361.
    PubMed         Abstract available
    
    
35. MOODIE Z, Andersen-Nissen E, Grunenberg N, Dintwe OB, et al
    Safety and immunogenicity of a subtype C ALVAC-HIV (vCP2438) vaccine prime plus bivalent subtype C gp120 vaccine boost adjuvanted with MF59 or alum in healthy adults without HIV (HVTN 107): A phase 1/2a randomized trial.
    PLoS Med. 2024;21:e1004360.
    PubMed         Abstract available
    
    
36. BRAZIER E, Tymejczyk O, Wools-Kaloustian K, Jiamsakul A, et al
    Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries.
    PLoS Med. 2024;21:e1004367.
    PubMed         Abstract available
    
    

    
    PLoS One

37. TUMWEGAMIRE A, Fatch R, Emenyonu NI, Lodi S, et al
    Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    PLoS One. 2024;19:e0300508.
    PubMed         Abstract available
    
    
38. SAGNIA B, Mbakop Ghomsi F, Moudourou S, Gutierez A, et al
    Accurate and reproducible enumeration of CD4 T cell counts and Hemoglobin levels using a point of care system: Comparison with conventional laboratory based testing systems in a clinical reference laboratory in Cameroon.
    PLoS One. 2024;19:e0297790.
    PubMed         Abstract available
    
    
39. JOHNSON SM, Teh JJ, Pasvol TJ, Ayres S, et al
    Hospitalisation rates for youth living with perinatally acquired HIV in England.
    PLoS One. 2024;19:e0295639.
    PubMed         Abstract available
    
    
40. GANTA AG, Wabeto E, Minuta WM, Wegi C, et al
    Predictors of loss to follow up among adults on antiretroviral therapy before and after the start of treat-all strategy in public health facilities of Hawassa city, Ethiopia: A Competing risk regression.
    PLoS One. 2024;19:e0299505.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

41. LAYISH B, Goli R, Flick H, Huang SW, et al
    Virus specificity and nucleoporin requirements for MX2 activity are affected by GTPase function and capsid-CypA interactions.
    PLoS Pathog. 2024;20:e1011830.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

42. SHICHIJO T, Yasunaga JI, Sato K, Nosaka K, et al
    Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
    Proc Natl Acad Sci U S A. 2024;121:e2309925121.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.